Pruritus Disease – Global Clinical Trials Review, H1 2020

Pages: 323 Published: May 30, 2020 Report Code: GDHC6209CTIDB

GlobalData's clinical trial report, “Pruritus Global Clinical Trials Review, H1, 2020" provides an overview of Pruritus Clinical trials scenario. This report provides top line data relating to the clinical trials on Pruritus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma – Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

– Assists in formulating key business strategies with regards to investment

– Helps in identifying prominent locations for conducting clinical trials which saves time and cost

– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

– Supports understanding of trials count and enrollment trends by country in global therapeutics market

– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

– Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Key Players

  • Cara Therapeutics Inc

    UCB SA

    Helsinn Group

    GlaxoSmithKline Plc

    Sanofi

    Trevi Therapeutics Inc

    Menlo Therapeutics Inc

    Toray Industries Inc

    Novartis AG

    Sienna Biopharmaceuticals Inc

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Pruritus to Dermatology Clinical Trials 17

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Pruritus to Dermatology Clinical Trials 20

Clinical Trials by Phase in E7 Countries 21

Clinical Trials in E7 Countries by Trial Status 22

Clinical Trials by Phase 23

In Progress Trials by Phase 24

Clinical Trials by Trial Status 25

Clinical Trials by End Point Status 26

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Pruritus Therapeutics Clinical Trials 31

Prominent Drugs 33

Latest Clinical Trials News on Pruritus 34

Mar 10, 2020: Asana BioSciences announces topical sodium channel blocker ASN008 achieves positive results for the treatment of Pruritus in Atopic Dermatitis 34

Feb 26, 2020: Menlo Therapeutics announces results from Phase 2 trial of Serlopitant in patients with chronic pruritus of unknown origin 34

Feb 25, 2020: Vanda reports results from the EPIONE study of tradipitant in the treatment of pruritus in atopic dermatitis 35

Feb 10, 2020: Elorac to present Naloxone Lotion Phase III study update at the 4th World Congress of Cutaneous Lymphomas in Barcelona 35

Clinical Trial Profile Snapshots 37

Appendix 324

Abbreviations 324

Definitions 324

Research Methodology 325

Secondary Research 325

About GlobalData 326

Contact Us 326

Source 327

List of Tables

List of Tables

Pruritus Therapeutics, Global, Clinical Trials by Region, 2020* 8

Pruritus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 10

Pruritus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

Pruritus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020* 12

Pruritus Therapeutics Clinical Trials, Europe, Top Five Countries, 2020* 13

Pruritus Therapeutics Clinical Trials, North America, Top Countries, 2020* 14

Pruritus Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020* 15

Pruritus Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020* 16

Proportion of Pruritus to Dermatology Clinical Trials, G7 Countries (%), 2020* 17

Pruritus Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 18

Pruritus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 19

Proportion of Pruritus to Dermatology Clinical Trials, E7 Countries (%), 2020* 20

Pruritus Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 21

Pruritus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 22

Pruritus Therapeutics, Global, Clinical Trials by Phase, 2020* 23

Pruritus Therapeutics, Global, Clinical Trials In Progress by Phase 2020* 24

Pruritus Therapeutics, Global, Clinical Trials by Trial Status, 2020* 25

Pruritus Therapeutics Clinical Trials, Global, by End Point Status, 2020* 26

Pruritus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 27

Pruritus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020* 28

Pruritus Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 30

Pruritus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 32

Pruritus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 33

List of Figures

List of Figures

Pruritus Therapeutics, Global, Clinical Trials by Region (%), 2020* 8

Pruritus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 9

Pruritus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

Pruritus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020* 12

Pruritus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020* 13

Pruritus Therapeutics Clinical Trials, North America, Top Countries (%), 2020* 14

Pruritus Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020* 15

Pruritus Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020* 16

Proportion of Pruritus to Dermatology Clinical Trials, G7 Countries (%), 2020* 17

Pruritus Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 18

Pruritus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 19

Proportion of Pruritus to Dermatology Clinical Trials, E7 Countries (%), 2020* 20

Pruritus Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 21

Pruritus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 22

Pruritus Therapeutics, Global, Clinical Trials by Phase (%), 2020* 23

Pruritus Therapeutics, Global, Clinical Trials In Progress by Phase, 2020* 24

Pruritus Therapeutics, Global, Clinical Trials by Trial Status, 2020* 25

Pruritus Therapeutics Clinical Trials, Global, by End Point Status, 2020* 26

Pruritus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 27

Pruritus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020* 28

Pruritus Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 29

Pruritus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 31

Pruritus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 33

GlobalData Methodology 325

Frequently Asked Questions

$2500

Can be used by individual purchaser only

$7500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.